Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.

246results about How to "Ensure compliance" patented technology

Watershed runoff drainage device & method

A watershed runoff drainage device is adapted to be used with a drain inlet vault for a storm drain. It includes a funnel member to be inserted into an inlet of the vault for directing substantially all water runoff entering the vault to flow there through prior to entering the vault. A floating hydrocarbon collector is positioned inside or outside the funnel member, and deflectors and other means within the vault inhibit the growth of mosquito larvae and the like within the vault and inhibit any mosquitoes within the vault from escaping the vault.

Metformin hydrochloride/voglibose sugar-lowering oral preparation composition and preparation method thereof

The invention provides a metformin hydrochloride / voglibose sugar-lowering oral preparation composition and a preparation method thereof. The weight ratio of two main medicines is 8000:1-375:1, preferably 2500:1-625:1. Except for the main medicines, the composition also can further contain commonly used medicine accessories, such as a binder, a filling agent, a disintegrating agent, a lubricant, a flavoring agent, a wetting agent and a flow agent, and the obtained composition can be prepared into tablets, granules, soft and hard capsules, sustained and controlled release preparations, optimum enteric-coated tablets, enteric-coated granules and enteric-coated soft and hard capsules by conventional methods. The composition provided by the invention has action mechanism complementation of the main medicines, multiple target points, good compliance of patients, and the like. The sugar-lowering oral preparation composition can be used for the first-line therapy of type 2 diabetes, or can be used for second-line therapy under the condition that the metformin hydrochloride or sulfonylurea medicines fail to singly and effectively control blood sugar; and the sugar-lowering oral preparation composition is especially suitable for the therapy of diabetic patients suffering from latent autoimmune diabetes in adults (LADA) and hyperinsulinemia.
Owner:北京瑞伊人科技发展有限公司 +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products